Sergio Casciaro

Dr. Sergio Casciaro

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in World Journal of Orthopedics
Verified
Journal Article
Open access
PPPaola Pisani
Paola Pisani
MRMaria Daniela Renna
Maria Daniela Renna
FCFrancesco Conversano
Francesco Conversano
ECErnesto Casciaro
Ernesto Casciaro
MPMarco Di Paola
Marco Di Paola
SCSergio Casciaro
Sergio Casciaro
Osteoporosis is a silent disease without any evidence of disease until a fracture occurs. Approximately 200 million people in the world are affected by osteoporosis and 8.9 million fractures occur each year worldwide. Fractures of the hip are a major public health burden, by means of both social cost and health condition of the elderly because these fractures are one of the main causes of morbidity, impairment, decreased quality of life and mortality in women and men. The aim of this review is to analyze the most important factors related to the enormous impact of osteoporotic fractures on population. Among the most common risk factors, low body mass index; history of fragility fracture, environmental risk, early menopause, smoking, lack of vitamin D, endocrine disorders (for example insulin-dependent diabetes mellitus), use of glucocorticoids, excessive alcohol intake, immobility and others represented the main clinical risk factors associated with augmented risk of fragility fracture. The increasing trend of osteoporosis is accompanied by an underutilization of the available preventive strategies and only a small number of patients at high fracture risk are recognized and successively referred for therapy. This report provides analytic evidences to assess the best practices in osteoporosis management and indications for the adoption of a correct healthcare strategy to significantly reduce the osteoporosis burden. Early diagnosis is the key to resize the impact of osteoporosis on healthcare system. In this context, attention must be focused on the identification of high fracture risk among osteoporotic patients. It is necessary to increase national awareness campaigns across countries in order to reduce the osteoporotic fractures incidence.

1 January 2013 in World Journal of Radiology
Verified
Journal Article
Closed access
PPPaola Pisani
Paola Pisani
MRMaria Daniela Renna
Maria Daniela Renna
FCFrancesco Conversano
Francesco Conversano
ECErnesto Casciaro
Ernesto Casciaro
MMMaurizio Muratore
Maurizio Muratore
SCSergio Casciaro
Sergio Casciaro
Effective prevention and management of osteoporosis would require suitable methods for population screenings and early diagnosis. Current clinically-available diagnostic methods are mainly based on the use of either X-rays or ultrasound (US). All X-ray based methods provide a measure of bone mineral density (BMD), but it has been demonstrated that other structural aspects of the bone are important in determining fracture risk, such as mechanical features and elastic properties, which cannot be assessed using densitometric techniques. Among the most commonly used techniques, dual X-ray absorptiometry (DXA) is considered the current "gold standard" for osteoporosis diagnosis and fracture risk prediction. Unfortunately, as other X-ray based techniques, DXA has specific limitations (e.g., use of ionizing radiation, large size of the equipment, high costs, limited availability) that hinder its application for population screenings and primary care diagnosis. This has resulted in an increasing interest in developing reliable pre-screening tools for osteoporosis such as quantitative ultrasound (QUS) scanners, which do not involve ionizing radiation exposure and represent a cheaper solution exploiting portable and widely available devices. Furthermore, the usefulness of QUS techniques in fracture risk prediction has been proven and, with the last developments, they are also becoming a more and more reliable approach for assessing bone quality. However, the US assessment of osteoporosis is currently used only as a pre-screening tool, requiring a subsequent diagnosis confirmation by means of a DXA evaluation. Here we illustrate the state of art in the early diagnosis of this "silent disease" and show up recent advances for its prevention and improved management through early diagnosis.


1 January 2015 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
FCFrancesco Conversano
Francesco Conversano
Roberto FranchiniRoberto Franchini
Roberto Franchini
AGAntonio Greco
Antonio Greco
GSGiulia Soloperto
Giulia Soloperto
FCFernanda Chiriacò
Fernanda Chiriacò
SCSergio Casciaro
Sergio Casciaro

9 May 2011 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
MMMaria Ada Malvindi
Maria Ada Malvindi
AGAntonio Greco
Antonio Greco
FCFrancesco Conversano
Francesco Conversano
AFAlbert Figuerola
Albert Figuerola
MCMaurizio Corti
Maurizio Corti
Andrea RagusaAndrea Ragusa
Andrea Ragusa

1 November 2010 in Investigative Radiology
Verified
Journal Article
Closed access
SCSergio Casciaro
Sergio Casciaro
FCFrancesco Conversano
Francesco Conversano
Andrea RagusaAndrea Ragusa
Andrea Ragusa
MMMaria Msc Ada Malvindi
Maria Msc Ada Malvindi
Roberto FranchiniRoberto Franchini
Roberto Franchini
GGGiuseppe Gigli
Giuseppe Gigli
Objectives: To experimentally investigate the acoustical behavior of silica nanoparticles within conventional diagnostic ultrasound fields and to determine a suitable configuration, in terms of particle size and concentration, for their employment as targetable contrast agents. We also assessed the effectiveness of a novel method for automatic detection of targeted silica nanoparticles for future tissue typing applications. Materials and Methods: Silica nanospheres of variable size (160, 330, and 660 nm in diameter) and concentration (1010–1013 part/mL) were dispersed in different custom-designed agarose-based gel samples and imaged at 7.5 MHz with a conventional echograph linked to a research platform for radiofrequency signal acquisition. Off-line analysis included evaluation of backscattered ultrasound amplitude, image brightness, and nanoparticle automatic detection through radiofrequency signal processing. Results: Amplitude of nanoparticle-backscattered signals linearly increased with particle number concentration, but image brightness did not show the same trend, because the logarithmic compression caused the reaching of a “plateau” where brightness remained almost constant for further increments in particle concentration. On the other hand, both backscatter amplitude and image brightness showed significant increments when particle diameter was increased. Taking into account particle size constraints for tumor targeting (pore size of tumor endothelium and trapping effects because of reticulo-endothelial system limit the dimension of effectively employable particles to less than 380 nm), a suitable compromise is represented by the employment of 330-nm silica nanospheres at a concentration of about 1 to 2 × 1011 part/mL. These particles, in fact, showed the best combination of number concentration and diameter value to obtain an effective enhancement on conventional echographic images. Furthermore, also the sensitivity of the developed method for automatic nanoparticle detection had a maximum (72.8%) with 330-nm particles, whereas it was lower with both bigger and smaller particles (being equal to 64.1% and 17.5%, respectively). Conclusions: Silica nanoparticles at a diameter of about 330 nm are very promising contrast agents for ultrasound imaging and specific tumor targeting at conventional diagnostic frequencies, being in particular automatically detectable with high sensitivity already at low doses. Future studies will be carried out to assess the acoustic behavior of nanoparticles with different geometries/sizes and to improve sensitivity of the automatic detection algorithm.